In a mouse model of TNBS colitis, intervention with the CXCR2 inhibitor SB225002 significantly reduced tissue damage, inflammation and levels of IL‐1β, MIP‐2, iNOS and KC, thereby improving survival.54 The gene discussed is CXCR2; the disease is colitis.